Vincerx Pharma, Inc.
VINC
$0.05
-$0.005-9.09%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.45% | -1.93% | -333.79% | 85.45% | -151.09% |
| Total Depreciation and Amortization | -- | 2.18% | 1.85% | 2.27% | 2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,675.64% | -95.24% | 137.15% | -177.02% | 1,072.19% |
| Change in Net Operating Assets | -211.35% | 422.39% | -460.80% | 109.57% | 65.78% |
| Cash from Operations | 27.94% | 3.10% | -9.45% | 24.69% | 3.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 422.20% | 116.48% | -- | -- |
| Cash from Investing | -- | 422.20% | 116.48% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 291.47% | -- | -100.00% | 339,940.00% | -72.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 291.47% | -- | -100.00% | 339,940.00% | -72.22% |
| Foreign Exchange rate Adjustments | -15.00% | 122.22% | 212.50% | -133.33% | 267.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.83% | 140.96% | -276.96% | 136.71% | -234.00% |